People with chronic dry eye syndrome suffer from eye ocular discomfort such as dry, painful, sandy gritty, tired, stinging symptoms with eyes that maybe very light sensitive. These symptoms can be . stubbornly persistent even with conventional dry eye remedies such as eye drops, punctal plugs, and more. There is a great amount of interest in the use of essential fatty acids (EFAs) as an adjunct in the treatment of chronic dry eye symptom. In heart diseases, Essential Fatty Acids, such as those in TheraLife Omega 3 Fish Oil have been shown to play a role in inflammatory processes leading to improved changes to the heart. The cause of dry eye is often inflammatory in nature, therefore, the anti-inflammatory actions of Omega 3 Fish Oil can really help people with chronic dry eye syndrome.
Foods and supplements containing Omega 3 are used to relief dry eye syndrome. . It is widely believed that omega-3 essential fatty acids, of which North Americans in particular are believed to have a very low normal dietary intake, may have benefits for maintaining normal tear production.
The two best sources of omega-3s are:
- dark, oily, cold-water fish
What is the difference between Omega 3 and Omega 6 Fatty Acids?
Omega-6s (the bad fatty acid) can promote dry eye syndrome. Omega 3 fatty acids can help relief dry eye syndrome.
People living in developed countries, especially Americans obtain an excess of omega-6s through their consumption of beef, dairy, vegetable shortening and cooking oils (i.e. hamburgers, cheeseburgers, pizza, ice cream, potato chips, etc.). It is thought that intake ratio of omega-3 to omega-6 fatty acids ideally should be at least 1:4 and preferably 1:2.3. However, the ratio is typically much lower in a diet typical of developed countries which tends to be high in meat and processed food. In one study, a high intake ratio of omega-3 to omega-6 fatty acids resulted in a decreased likelihood of suffering from dry eye syndrome, while women with lower than a 1:15 omega-3/omega-6 fatty acids ratio had a 2.5 times greater prevalence of dry eye syndrome. If too much omega-6 fatty acid is ingested due to a diet high in processed meats and low in unprocessed oils and omega-3 fatty acids, then increased levels of pro-inflammatory prostaglandin E2 (PGE2), and low levels of anti-inflammatory agents PGE1 and PGE3, may lead to dry eye. The effectiveness of essential fatty acids as a treatment for dry eye syndrome is dependent on the proper balance of omega-6 and omega-3 fatty acids.
Omega 3 fatty acid help reduce Meibomian Gland Dysfunction.
The effectiveness of fatty acid treatment of dry eye syndrome is also dependent on specific nutrient cofactors that aid the metabolic conversion to anti-inflammatory prostaglandins. These nutrient cofactors stimulate the production of healthy goblet cells and enhance production of clearer and thinner meibomian gland secretion. Omega-3 fatty acids also play an important role in the synthesis of meibum, the oil secreted by meibomian glands. People with omega-3 fatty acid deficiency typically have a thicker meibomian gland secretion. The use of omega-3 fatty acid supplements results in clearing and thinning of meibomian gland secretions which in turn improves symptoms of dry eye. Properly designed formulations also encourage lacrimal gland secretion and the production of tear lactoferrin.
TheraLife® Omega-3 Fish Oil- Molecularly DistilledTheraLife®Dry Eye Enhanced and TheraLife® Omega-3 Fish Oil taken together provides added benefits
- Reduce chronic inflammation from dry eye conditions.
- Produces a better quality tear that prevents excessive tear evaporation.
- Reduce risk of Macular Degeneration, Cataract and other various age related eye disorders.
- Omega-3's benefit other regions of the body including the brain, immune system, cardiovascular system and the skin.
TheraLife® Omega-3 Fish Oil is molecularly distilled to reduce levels of mercury and other contaminants. We provide the highest levels of
Follow us on
Send email inquiries to: firstname.lastname@example.org
Referance: Optometric Management, Feb, 2012